NEW YORK (Reuters Health) - Some women with factor XI deficiency, a genetic disorder, have an excessive risk of bleeding after childbirth, UK researchers report in the current issue of BJOG. Factor XI ...
Factor deficiency or inhibition. The possible causes of the isolated prolonged aPTT in this case include factor deficiencies and factor inhibitors. Prolongation of both the PT and aPTT suggests ...
The oral factor XIa inhibitor milvexian across a range of doses is associated with a lower risk of venous thromboembolism (VTE) after knee arthroplasty than subcutaneous enoxaparin (Lovenox) without ...
Secondary endpoints also showed a highly significant 67% reduction in major bleeding and an 89% reduction in gastrointestinal (GI) bleeding The company’s AZALEA-TIMI 71 study is the longest ...
Welcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...
Regeneron Pharmaceuticals has announced positive Phase 2 results for two investigational monoclonal antibodies, REGN7508 and REGN9933, which target different domains of Factor XI to control thrombosis ...
If the novel factor XI inhibitor abelacimab reaches the market for patients with atrial fibrillation (AF) who require anticoagulation, it may not be necessary to interrupt treatment ahead of invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results